Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Swedish Orphan Biovitrum

411.00 SEK

+1.23 %

Less than 1K followers

SOBI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue6,894.07,435.026,027.06,465.06,175.07,776.07,822.028,238.0
EBITDA2,962.02,638.09,304.02,296.01,899.03,656.03,112.010,963.0
EBIT2,038.01,662.05,625.01,358.01,010.0-3,858.02,357.0867.0
EBIT-%29.6 %22.4 %21.6 %21.0 %16.4 %-49.6 %30.1 %3.1 %
Profit before taxes1,712.01,438.04,407.01,096.0794.0-4,027.02,171.034.0
Net income1,464.01,391.03,879.0875.0634.0-2,895.01,862.0476.0
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.